Spots Global Cancer Trial Database for positron emission tomography (pet) scan
Every month we try and update this database with for positron emission tomography (pet) scan cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
68-Ga-FAPI PET Imaging in Malignancy | NCT04023240 | Cancer | 68Ga-FAPI Computed Tomogr... Positron Emissi... | 19 Years - 99 Years | Stanford University | |
A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With Cemiplimab | NCT05259709 | Advanced Solid ... Metastatic Soli... | 89Zr˗DFO˗REGN50... cemiplimab | 18 Years - | Regeneron Pharmaceuticals | |
Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract | NCT04069299 | Neuroendocrine ... | 68Ga-DOTATATE Positron Emissi... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE) | NCT04410367 | Brain Metastase... | 18F fluciclovin... | 18 Years - | Blue Earth Diagnostics | |
68-Ga-FAPI PET Imaging in Malignancy | NCT04023240 | Cancer | 68Ga-FAPI Computed Tomogr... Positron Emissi... | 19 Years - 99 Years | Stanford University | |
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases | NCT00375830 | Cancer | Bone scan 99mTc-methyl di... Positron Emissi... 18F-Fludeoxyglu... Computed Tomogr... 18F-Sodium Fluo... Whole Body Magn... Gadopentetate d... Gadofosveset Gadobutrol | 18 Years - | Stanford University | |
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases | NCT00375830 | Cancer | Bone scan 99mTc-methyl di... Positron Emissi... 18F-Fludeoxyglu... Computed Tomogr... 18F-Sodium Fluo... Whole Body Magn... Gadopentetate d... Gadofosveset Gadobutrol | 18 Years - | Stanford University | |
68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer | NCT02440308 | Prostate Carcin... | 68Ga-DOTA-Bombe... Magnetic Resona... Positron Emissi... | 19 Years - | Stanford University | |
Imaging Study to Investigate Safety and Diagnostic Performance of rhPSMA 7.3 (18F) PET Ligand in Suspected Prostate Cancer Recurrence (SPOTLIGHT) | NCT04186845 | Prostate Cancer | rhPSMA-7.3 (18F... | 18 Years - | Blue Earth Diagnostics | |
Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE) | NCT04410367 | Brain Metastase... | 18F fluciclovin... | 18 Years - | Blue Earth Diagnostics | |
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer | NCT00123760 | Brain Neoplasms Lung Neoplasms Thyroid Neoplas... Colorectal Neop... Lymphoma | Positron Emissi... | 15 Years - | AHS Cancer Control Alberta | |
68-Ga-FAPI PET Imaging in Malignancy | NCT04023240 | Cancer | 68Ga-FAPI Computed Tomogr... Positron Emissi... | 19 Years - 99 Years | Stanford University | |
Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases | NCT04410133 | Brain Metastase... | 18F fluciclovin... | 18 Years - | Blue Earth Diagnostics | |
Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract | NCT04069299 | Neuroendocrine ... | 68Ga-DOTATATE Positron Emissi... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |